Gout

POS0513 QUALITY OF LIFE AND CLINICAL GOUT ASSESSMENT CHANGES IN UNCONTROLLED GOUT PATIENTS UNDERGOING PEGLOTICASE THERAPY AS PART OF THE MIRROR RANDOMIZED CONTROLLED TRIAL
J. Botson, K. Obermeyer, B. Lamoreaux, L. Padnick-Silver, S. Verma, M. E. Weinblatt, J. Peterson

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 518-519; DOI: 10.1136/annrheumdis-2023-eular.2367
POS0530 ANALYSIS OF APPROPRIATE DURATION OF COLCHICINE PROPHYLAXIS TO MAXIMIZE THE PERSISTENCE OF XANTHINE OXIDASE INHIBITORS AS THE FIRST-LINE URATE LOWERING THERAPY IN PATIENTS WITH GOUT USING THE KOREAN HEALTH INSURANCE REVIEW AND ASSESSMENT SERVICE DATABASE: DOES 6 MONTHS’ DURATION MATTER?
A. Kim, S. G. Lee, B. W. Song, D. H. Moon

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 529; DOI: 10.1136/annrheumdis-2023-eular.2161
POS0587-HPR IMPACT OF COMBINED INTERVENTION WITH CLINICAL NURSE SPECIALIST IN THE MANAGEMENT OF CARDIOVASCULAR RISK IN PATIENTS WITH GOUT
E. Calvo-Aranda, C. M. Gomez-Gonzalez, J. A. Angel-Sesmero, M. Novella-Navarro, P. Cardoso Peñafiel

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 563-564; DOI: 10.1136/annrheumdis-2023-eular.6484
POS1201-HPR ADVANCED PRACTICE RHEUMATOLOGY NURSING FOR PATIENTS WITH GOUT TARGETS URATE, KNOWLEDGE, AND LIFESTYLE TO ENHANCE CHRONIC DISEASE OUTCOME
M. O’neill, D. Veale, E. Molloy, C. Orr, P. Minnock

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 933; DOI: 10.1136/annrheumdis-2023-eular.1537
AB1237 ASSOCIATION OF GUT MICROBIOTA WITH RISK OF GOUT
Y. Zhang, Y. Niu, Z. Han, Q. Yu, P. F. He, X. Li, S. X. Zhang

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1845; DOI: 10.1136/annrheumdis-2023-eular.3743
POS0528 PATIENT EXPERIENCES WITH CHRONIC REFRACTORY GOUT AND ITS IMPACT ON HEALTH-RELATED QUALITY OF LIFE
A. Oladapo, V. Strand, N. Kragh, N. Johnson, C. Yousefian, D. Brooks, H. Sharp, C. Kim, M. Pillinger

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 527-528; DOI: 10.1136/annrheumdis-2023-eular.1389
OP0154 TOPHI AND CAROTID PLAQUE WERE RISK FACTORS OF MACE IN GOUTY ARTHRITIS PATIENTS: A LONGITUDINAL COHORT STUDY
Y. Wang, Z. Zhang

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 102; DOI: 10.1136/annrheumdis-2023-eular.1231
OP0155 CLINICAL IMPACT OF CARDIOVASCULAR MONOSODIUM URATE DEPOSITS MEASURED BY DUAL ENERGY COMPUTED TOMOGRAPHY: A RETROSPECTIVE EVALUATION
J. Held, C. Schwabl, G. Feuchtner, C. Duftner, G. Weiss, A. Klauser

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 102-103; DOI: 10.1136/annrheumdis-2023-eular.2616
LB0002 SAFETY & EFFICACY OF SEL-212 IN PATIENTS WITH GOUT REFRACTORY TO COVENTIONAL TREATMENT: OUTCOMES FROM TWO RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE III STUDIES
H. S. B. Baraf, A. Kivitz, S. Rhodes, S. Leung, O. Folarin, T. Gonzalez-Rivera, J. Sobierska, J. Christie, A. Patel, W. Dehaan, R. Azeem, P. Traber

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 200-201; DOI: 10.1136/annrheumdis-2023-eular.7084
OP0095 MONOSODIUM URATE AND CALCIUM PYROPHOSPHATE CRYSTAL-INDUCED INFLAMMATION RELIES ON CELL VOLUME REGULATION AND LRRRC8/VRAC CHANNEL ACTIVATION
T. W. Chirayath, M. Kayatekin, I. Rubera, N. Pham, F. Lioté, P. Richette, V. Compan, F. Rassendren, C. Duranton, H. K. Ea

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 64; DOI: 10.1136/annrheumdis-2023-eular.4787

Main menu

Gout

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Gout

Pages